Literature DB >> 4374231

Significance of serum factors modifying cellular immune responses to growing tumours.

R W Baldwin, M R Price, R A Robins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4374231      PMCID: PMC2149052     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


× No keyword cloud information.
  21 in total

1.  Demonstration by colony inhibition methods of cellular and humoral immune reactions to tumour-specific antigens associated with aminoazo-dye-induced rat hepatomas.

Authors:  R W Baldwin; M J Embleton
Journal:  Int J Cancer       Date:  1971-01-15       Impact factor: 7.396

2.  Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status.

Authors:  R W Baldwin; M J Embleton; R A Robins
Journal:  Int J Cancer       Date:  1973-01-15       Impact factor: 7.396

3.  Tumour-specific antigenicity of aminoazo-dye-induced rat hepatomas.

Authors:  R W Baldwin; C R Barker
Journal:  Int J Cancer       Date:  1967-07-15       Impact factor: 7.396

Review 4.  Immunological enhancement as studied by cell culture techniques.

Authors:  K E Hellström; I Hellström
Journal:  Annu Rev Microbiol       Date:  1970       Impact factor: 15.500

5.  Studies on cellular immunity and its serum mediated inhibition in Moloney-virus-induced mouse sarcomas.

Authors:  I Hellström; K E Hellström
Journal:  Int J Cancer       Date:  1969-09-15       Impact factor: 7.396

6.  Colony inhibition studies on blocking and non-blocking serum effects on cellular immunity to Moloney sarcomas.

Authors:  I Hellström; K E Hellström
Journal:  Int J Cancer       Date:  1970-03-15       Impact factor: 7.396

7.  Cellular and humoral immune responses to human urinary bladder carcinomas.

Authors:  J Bubeník; P Perlmann; K Helmstein; G Moberger
Journal:  Int J Cancer       Date:  1970-05-15       Impact factor: 7.396

8.  Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas.

Authors:  I Hellström; K E Hellström; H O Sjögren
Journal:  Cell Immunol       Date:  1970-05       Impact factor: 4.868

9.  Demonstration of tumour-specific humoral antibody against aminoazo dye-induced rat hepatomata.

Authors:  R W Baldwin; C R Barker
Journal:  Br J Cancer       Date:  1967-12       Impact factor: 7.640

10.  The presence of tumour-specific membrane antigen in the serum of rats with chemically induced sarcomata.

Authors:  D M Thomson; K Steele; P Alexander
Journal:  Br J Cancer       Date:  1973-01       Impact factor: 7.640

View more
  8 in total

Review 1.  Feline leukemia virus: current status of the feline induced immune depression and immunoprevention.

Authors:  R G Olsen; M G Lewis; L J Lafrado; L E Mathes; K Haffer; R Sharpee
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Enhancement of mechanisms acting against mammary carcinoma: pancreatic trypsin inhibitor.

Authors:  A A Hakim
Journal:  Klin Wochenschr       Date:  1978-08-01

3.  Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.

Authors:  H Teshima; H Wanebo; C Pinsky; N K Day
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

4.  The relationship between cytotoxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast.

Authors:  I J Check; M Cobb; R L Hunter
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

5.  Pathopysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis, and pathogenic depositions.

Authors:  H H Sedlacek
Journal:  Klin Wochenschr       Date:  1980-06-16

6.  [The lymphocyte cytotoxicity test in tumor immunology (author's transl)].

Authors:  H W Pees
Journal:  Klin Wochenschr       Date:  1975-01

7.  Effects of staphylococcal protein A-treated human leukemic serum on autologous leukemic blast growth and mitogenesis of lymphocytes.

Authors:  T R Spitzer; H M Lazarus
Journal:  J Clin Immunol       Date:  1984-11       Impact factor: 8.317

8.  Lymphocyte reactivity in patients with carcinoma of the breast and large bowel.

Authors:  J J Miller; P R Gaffney; J A Rees; M O Symes
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.